Floatz logo

CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)-

Chronic Neuropathic Pain

Boston Children's HospitalSmall moleculePhase 4 / ApprovedActive
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
89/ 100

Competitive context

6 Active assets in the Chronic Neuropathic Pain cohort.

Asset / SponsorPhaseRating
NEPENTHE
Nova Scotia Health Authority
Phase 4BB
Amitriptyline
UMC Utrecht
Phase 4BB
Naltrexone
Emory University
Phase 4BB
METHADONE
Nova Scotia Health Authority
Phase 4BB
FENTANYL
Cephalon
Phase 3B

View all 10 →

Same molecule, other indications

CYCLOHEXANEACETIC ACID, 1-(AMINOMETHYL)- is also rated in:

diabetic neuropathyDormant
BBB
Indicative ·
79 / 100
View asset →
Neuralgia, PostherpeticDormant
BBB
Indicative ·
77 / 100
View asset →
focal epilepsyDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →